Isemann MD. Treatment of multidrug resistant tuberculosis.N Engl J Med 1993; 329:784–791.
Article
Google Scholar
Dooley SW, Jarvis WR, Martone WJet al. Multidrug resistant tuberculosis.Ann Intern Med 1992;117:257–258.
PubMed
CAS
Google Scholar
Raviglione MC, Snider Snider DE, Kochi A. Global epidemiology of tuberculosis Morbidity and Mortality of a world wide epidemic.JAMA 1995;273:220–226.
PubMed
Article
CAS
Google Scholar
Vareldzis BP, Grosset J, Kantor IDet al. Laboratory evaluation of drug resistant tuberculosis. Document WHO/TB. 1993; 171:3–16.
Google Scholar
Heym B, Cole ST. Isolation and characterization of isoniazid-resistant mutants of M. Smegmatis.Res Microbiol 143:721–730.
Cole ST. Mechanisms of drug resistance in Mycobacterium tuberculosis.Immunobiol 1994;191:584–585.
CAS
Google Scholar
Winder FG, Collins PB. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis.J Gen Microbiol 1970;63:41–48.
PubMed
CAS
Google Scholar
Freiden TR, Sterling T, Pablos M. The emergence of drug resistant tuberculosis in New York City.N Engl J Med 1993;328:521–526.
Article
Google Scholar
Goble M, Iseman MD, Madsen LAet al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin.N Engl J Med 1993;328:527–532.
PubMed
Article
CAS
Google Scholar
Snider DE, Cauthen GM, Farer LSet al. Drug resistant tuberculosis.Am Rev Respir Dis 1991;144:732–736.
PubMed
Google Scholar